Related Experiment Video
Updated: Jul 12, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Protein S: a vitamin K-dependent factor bridging haemostasis, tissue homeostasis and cancer
Omar Benzakour1, Yousra Kaissouni1, Olivier E Pardo2
1Université de Poitiers, CHU de Poitiers, ProDiCeT, UR 24144, Poitiers, France.
Abstract:
Protein S (PROS1) is a vitamin K-dependent plasma glycoprotein that was originally described as a non-enzymatic cofactor of activated protein C in the regulation of blood coagulation. Over the past three decades, PROS1 has emerged as a pleiotropic signaling molecule with functions that extend far beyond hemostasis. PROS1 is a ligand for the TAM family receptor tyrosine kinases TYRO3 and MERTK and, as such, regulates diverse cellular processes including proliferation, migration, phagocytosis, vascular homeostasis, and immune modulation. These activities are mediated through both circulating and locally produced PROS1 and are pathological context-dependent. In the present review, we first summarize our current knowledge on the regulation of PROS1 gene expression and protein structure. We then discuss its established anticoagulant mechanisms alongside emerging activated protein C-independent functions. Finally, we examine key regulatory roles of protein S-TAM signaling in the vessel wall, central nervous system, inflammation, and cancer. Collectively, these findings position PROS1 as a molecular integrator of coagulation, immunity, and tissue homeostasis and underscore its relevance as both a biomarker and a potential therapeutic target in a broad range of pathophysiological contexts.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
